We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The director of the US National Institutes of Health (NIH), Elías Zerhouni, has highlighted the potential of Puerto Rico in biotech research. During a meeting with local officials, Zerhouni noted that last year NIH directly contributed US$60mn in R&D spending to Puerto Rico.
Representatives of the European, Japanese and US drug industries have submitted reform proposals for Japan's National Health Insurance (NHI) reimbursement system.
Solvay Pharmaceuticals, Inc. announced today that it has signed a collaboration agreement with the Mayo Foundation for Medical Education and Research to investigate a novel mechanism of action to treat gastrointestinal motility disorders.
Health Minister Datuk Dr Chua Soi Lek said the uncaring attitude of consumers concerning the genuineness of health and pharmaceutical products has led to the rampant dumping of unregistered products in the market.
Meiji Dairies has agreed with Takeda Pharmaceutical to terminate their joint development contract for TAK-201, a drug candidate for treating hay fever.
Sawai Pharmaceutical (TSE: 4555) announced on August 2 that it will take over the production and sales operations for three ethical products from Nihon Schering.
Spanish chemicals and biotech company Zeltia (ZEL.MC: Quote, Profile, Research) said on Thursday it will invest 155 million euros ($190.9 million) until 2007 in its fledgling pharmaceutical units PharmaMar and Neuropharma.
The UAE's US$700mn drug market appears to have given rise to a thriving fake drug trade, as illegal manufacturers are increasingly tempted by high prices for legitimate products.